In vitro inhibition studies of tolbutamide hydroxylase activity of human liver microsomes by azoles, sulphonamides and quinolines.

British Journal of Clinical Pharmacology

Volumn 26, Issue 1, 1988, Pages 23-29

  Back, DJ ^a   Tjia, JF ^a   Karbwang, J ^a   Colbert, J ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYLIMIDAZOLE; 2 METHYLIMIDAZOLE; 4 METHYLIMIDAZOLE; CIMETIDINE; CLOTRIMAZOLE; DAPSONE; FLUCONAZOLE; HISTAMINE; KETOCONAZOLE; MEFLOQUINE; METRONIDAZOLE; MICONAZOLE; PYRIMETHAMINE; QUINIDINE; QUININE; QUINOLINE DERIVATIVE; SULFADOXINE; SULFAMETHIZOLE; SULFAMETHOXAZOLE; SULFANILAMIDE; SULFAPHENAZOLE; SULFONAMIDE; TERCONAZOLE; THIAMAZOLE; UNCLASSIFIED DRUG;

DRUG COMPARISON; ENZYME INHIBITION; HUMAN; HUMAN CELL; LIVER MICROSOME; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AZOLES; CHILD; CHILD, PRESCHOOL; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; HUMAN; IN VITRO; KINETICS; MALE; MICROSOMES, LIVER; MIDDLE AGE; MIXED FUNCTION OXYGENASES; PROTEINS; QUINOLINES; SULFONAMIDES; TOLBUTAMIDE;

EID: 0023924549     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.1988.tb03359.x     Document Type: Article

References (41)

1. Sulphaphenazole and drug oxidation in man
2. Effect of chloroquine and primaquine on antipyrine metabolism
3. Inhibition of drug metabolism by the antimalarial drugs chloroquine and primaquine in the rat
4. Tolbutamide as a model drug for the study of enzyme induction and enzyme inhibition in the rat
5. Inhibition of tolbutamide metabolism by substituted imidazole drugs in vivo: evidence for a structure‐activity relationship
6. Selective inhibition of drug oxidation after simultaneous administration of two probe drugs antipyrine and tolbutamide
7. Partial purification of human liver cytochrome P‐450
8. Comparison of monooxygenase activities and cytoschrome P‐450 isozyme concentrations in human liver microsomes
9. Effect of ketoconazole on hepatic oxidative drug metabolism
10. Inhibition of tolbutamide elimination by cimetidine but not ranitidine
11. Sulphaphenazole induced hypoglycaemic attacks in tolbutamide treated diabetics
12. Cyclosporin A: A clinical evaluation of drug interactions
13. The effect of cimetidine on tolbutamide kinetics
14. Purification and characterization of the human liver cytochromes P‐450 involved in debrisoquine 4‐hydroxylation and phenacetin‐o‐deethylation, two prototypes for genetic polymorphism in oxidative drug metabolism
15. The determination of enzyme inhibitor constants
16. Oxidation of quinidine by human liver cytochrome P‐450
17. Polymorphism of human cytochrome P‐450
18. Characterization and inhibition of mephenytoin 4‐hydroxylase activity in human liver microsomes
19. In vitro inhibition studies of two isozymes of human liver cytochrome P‐450
20. Genetic variation in the human hepatic cytochrome P‐450 system
21. Hepatic metabolism of tolbutamide: Characterisation of the form of cytochrome P‐450 involved in methyl hydroxylation and relationship to in vivo disposition
22. Interaction of miconazole, ketoconazole and itraconazole with rat liver microsomes
23. Protein measurement with the Folin phenol reagent
24. Sulfamethizole‐induced inhibition of diphenylhydantoin, tolbutamide and warfarin metabolism
25. The effect of ketoconazole on hepatic oxidative drug metabolism in the rat in vivo and in vitro
26. The effects of primaquine stereoisomers and metabolites on drug metabolism in the isolated perfused rat liver and in vitro rat liver microsomes
27. In vitro effects of quinoline derivatives on cytochrome P‐450 and aminopyrine N‐demethylase activity in rat hepatic microsomes
28. The carbon‐monoxidebinding pigment of liver microsomes
29. Mechanisms of inhibition of tolbutamide metabolism: phenylbutazone, oxyphenbutazone, sulphaphenazole
30. Tolbutamide 4‐hydroxylase activity of human liver microsomes: Effect of inhibitors
31. The metabolism of 17α‐ethinyloestradiol by human liver microsomes: formation of catechol and chemically reactive metabolites
32. Effect of mefloquine on hepatic drug metabolism in the rat: comparative study with primaquine
33. Inhibition of ethinyloestradiol and tolbutamide metabolism by quinoline derivatives in vitro
34. Kinetics of drug‐drug interactions
35. Abbauhemmung von Tolbutamid durch sulfaphenazol beim Menschen
36. Ketoconazole: A potent inhibitor of cytochrome P‐450 dependent drug metabolism in rat liver
37. Inhibition of rat liver microsomal cytochrome P‐450 steroid hydroxylase reaction by imidazole antimycotic agents
38. Lack of inhibition of tolbutamide hydroxylation by cimetidine in man
39. Inhibition of rat hepatic mixed function oxidases by the antimalarial drugs: selectivity for cytochromes P‐450 and P‐448
40. Purification and characterisation of six cytochrome P‐450 isozymes from human liver microsomes
41. Determination of the mechanisms and constants of inhibition